Investing for over 30 years, spent some time as a broker. Very interested in markets and geopolitical effects.
Nature and animal lover, interested in health and nutrition, history buff, investments skewed to the biotech sector.
Montie has spent his career in the telecom and technology industries in various sales, marketing and business development roles. Currently, Montie helps businesses identify business and product strategies that leverage their strengths to grow their business. Montie has been an equity investor since the 1980s.
John received his PhD in chemistry in the research group of Nobel Laureate Donald Cram in 1987 and his MBA from the Anderson School of Management at UCLA in 2009. His research career spans 16 years performing drug discovery research in metabolic diseases, cancer, HIV infection, antibacterials, and Alzheimer's disease. In 2011 John joined Sagient Research Systems as a Biotechnology Analyst. In 2013 he joined Zack's Small Cap Research as an Analyst.
On Twitter: @johntuckerphd
As John is neither licensed nor qualified to act as an investment advisor, his articles are written for discussion purposes only and should not be construed as investment advice. He makes a reasonable effort to avoid misstatements of fact, but advises all investors to consult primary sources prior to making an investment.